February 4, 2025
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn.: | Tim Buchmiller |
| Office of Life Sciences |
| Re: | OS Therapies Incorporated | |
| Registration Statement on Form S-1 (No. 333-284631) |
Ladies and Gentlemen:
OS Therapies Incorporated hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:30 p.m., Eastern time, on Thursday, February 6, 2025, or as soon as practicable thereafter.
| Very truly yours, | ||
| OS Therapies Incorporated | ||
| By: |
/s/ Paul A. Romness | |
| Paul A. Romness | ||
| President and Chief Executive Officer | ||